Literature DB >> 18230609

Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis.

Baoying Liu1, Zhuqing Li, Sankaranarayana P Mahesh, Seth Pantanelli, Frank S Hwang, Willie O Siu, Robert B Nussenblatt.   

Abstract

Glucocorticoid-induced tumor necrosis factor receptor (GITR), found constitutively expressed on human primary natural killer (NK) cells at low levels was up-regulated upon stimulation by either Toll-like receptor ligand or NK cell growth factor, interleukin (IL)-15. cDNA microarray analysis showed that engagement of GITR primarily suppressed the activation of NF-KB pathway of NK cells and up-regulated anti-inflammatory genes heme oxygenase-1 and IL-10. Further analysis revealed that GITR activation suppressed NK cell proliferation in response to IL-15. GITR activation also suppressed proinflammatory cytokine secretion and increased NK cell apoptosis. GITR activation resulted in blocked phosphorylation of Stat5 and Akt, which may have contributed to the observed antiproliferative effect of GITR on NK cells. Increased apoptosis was independent of the Fas-FasL pathway, but Bcl-XL and phospho-Bad protein expressions were diminished, suggesting involvement of the mitochondrial apoptosis pathway. The results suggest that although GITR is an activation marker for NK cells similar to that for T cells, GITR serves as a negative regulator for NK cell activation. Our studies demonstrate a novel physiological role of GITR on NK cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230609      PMCID: PMC2276384          DOI: 10.1074/jbc.M708944200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand.

Authors:  B Kwon; K Y Yu; J Ni; G L Yu; I K Jang; Y J Kim; L Xing; D Liu; S X Wang; B S Kwon
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

Review 2.  Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia.

Authors:  Pak H Chan
Journal:  Neurochem Res       Date:  2004-11       Impact factor: 3.996

3.  Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods.

Authors:  H Lecoeur; E Ledru; M C Prévost; M L Gougeon
Journal:  J Immunol Methods       Date:  1997-12-01       Impact factor: 2.303

4.  A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis.

Authors:  G Nocentini; L Giunchi; S Ronchetti; L T Krausz; A Bartoli; R Moraca; G Migliorati; C Riccardi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 5.  TNF/TNFR family members in costimulation of T cell responses.

Authors:  Tania H Watts
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 6.  GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily.

Authors:  Giuseppe Nocentini; Carlo Riccardi
Journal:  Eur J Immunol       Date:  2005-04       Impact factor: 5.532

7.  Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis.

Authors:  Zhuqing Li; Wee Kiak Lim; Sankaranarayana P Mahesh; Baoying Liu; Robert B Nussenblatt
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

8.  TRAF4 functions as an intermediate of GITR-induced NF-kappaB activation.

Authors:  E M Esparza; R H Arch
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

9.  Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.

Authors:  Adam D Cohen; Adi Diab; Miguel-Angel Perales; Jedd D Wolchok; Gabrielle Rizzuto; Taha Merghoub; Deonka Huggins; Cailian Liu; Mary Jo Turk; Nicholas P Restifo; Shimon Sakaguchi; Alan N Houghton
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 10.  Fas and the art of lymphocyte maintenance.

Authors:  M J Lenardo
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  21 in total

Review 1.  Modulation of GITR for cancer immunotherapy.

Authors:  David A Schaer; Judith T Murphy; Jedd D Wolchok
Journal:  Curr Opin Immunol       Date:  2012-01-12       Impact factor: 7.486

Review 2.  Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.

Authors:  Giuseppe Nocentini; Simona Ronchetti; Maria Grazia Petrillo; Carlo Riccardi
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis.

Authors:  J Wild; B J Schmiedel; A Maurer; S Raab; L Prokop; S Stevanović; D Dörfel; P Schneider; H R Salih
Journal:  Leukemia       Date:  2015-02-24       Impact factor: 11.528

4.  Generation and preclinical characterization of a Fc-optimized GITR-Ig fusion protein for induction of NK cell reactivity against leukemia.

Authors:  Benjamin Joachim Schmiedel; Antje Werner; Julia Steinbacher; Tina Nuebling; Corina Buechele; Ludger Grosse-Hovest; Helmut Rainer Salih
Journal:  Mol Ther       Date:  2013-02-05       Impact factor: 11.454

5.  GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis.

Authors:  Linbo Li; Wen Wen; Rulin Jia; Yuhui Li; Xu Liu; Xiaolin Sun; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2016-04-21       Impact factor: 2.980

Review 6.  Integrating costimulatory agonists to optimize immune-based cancer therapies.

Authors:  Angela D Pardee; Amy K Wesa; Walter J Storkus
Journal:  Immunotherapy       Date:  2009-03       Impact factor: 4.196

Review 7.  Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.

Authors:  Theresa Placke; Hans-Georg Kopp; Helmut Rainer Salih
Journal:  Clin Dev Immunol       Date:  2010-09-26

Review 8.  CD8+ T cells: GITR matters.

Authors:  Simona Ronchetti; Giuseppe Nocentini; Maria Grazia Petrillo; Carlo Riccardi
Journal:  ScientificWorldJournal       Date:  2012-04-30

9.  The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.

Authors:  Isabel Barao
Journal:  Front Immunol       Date:  2013-01-04       Impact factor: 7.561

10.  Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma.

Authors:  Yang Liu; Phong Quang; Esteban Braggio; Hai Ngo; Gayane Badalian-Very; Ludmila Flores; Yong Zhang; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Feda Azab; Ruben Carrasco; Barrett J Rollins; Aldo M Roccaro; Irene M Ghobrial
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.